BE890024A - Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques - Google Patents

Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques

Info

Publication number
BE890024A
BE890024A BE0/205721A BE205721A BE890024A BE 890024 A BE890024 A BE 890024A BE 0/205721 A BE0/205721 A BE 0/205721A BE 205721 A BE205721 A BE 205721A BE 890024 A BE890024 A BE 890024A
Authority
BE
Belgium
Prior art keywords
preparation
therapeutic uses
imidazole derivatives
tricyclic imidazole
tricyclic
Prior art date
Application number
BE0/205721A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE890024A publication Critical patent/BE890024A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/50—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions decreasing the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE0/205721A 1980-08-21 1981-08-20 Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques BE890024A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH632180A CH644116A5 (de) 1980-08-21 1980-08-21 Imidazolderivate.

Publications (1)

Publication Number Publication Date
BE890024A true BE890024A (fr) 1982-02-22

Family

ID=4307711

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/205721A BE890024A (fr) 1980-08-21 1981-08-20 Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques

Country Status (20)

Country Link
US (3) US4435406A (fr)
JP (1) JPS5770886A (fr)
AT (1) AT376665B (fr)
AU (1) AU541834B2 (fr)
BE (1) BE890024A (fr)
CA (1) CA1134829A (fr)
CH (1) CH644116A5 (fr)
DE (1) DE3132613A1 (fr)
DK (1) DK300981A (fr)
FR (1) FR2488890A1 (fr)
GB (1) GB2082580B (fr)
IE (1) IE51507B1 (fr)
IL (1) IL63576A (fr)
IT (1) IT1138156B (fr)
LU (1) LU83571A1 (fr)
NL (1) NL8103690A (fr)
NZ (1) NZ198047A (fr)
PH (1) PH17937A (fr)
SE (1) SE452765B (fr)
ZA (1) ZA815633B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746667A (en) * 1981-08-13 1988-05-24 Aktiebolaget Hassle Pharmaceutical composition containing 2-(2-benzimidazolyl thiomethyl) pyridine
EP0233284B1 (fr) * 1985-10-29 1992-08-19 Aktiebolaget Hässle Composes pharmaceutiques
EP0510719A1 (fr) 1986-11-21 1992-10-28 Aktiebolaget Hässle Dérivés de benzimidazol substitués par un group radical et leur utilisation pour l'inhibition de la sécrétion gastrique
LT3810B (en) 1986-11-21 1996-03-25 Haessle Ab New benzimidazole derivatives, a process for production thereof and a pharmaceuticalcomposition containing the same

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
US4686232A (en) * 1983-02-28 1987-08-11 Sumitomo Chemical Company, Limited Fungicidal aniline derivatives
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
HU191757B (en) * 1983-05-03 1987-04-28 Byk Gulden Lomberg Chem Fab Process for producing new tricyclic ethers
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
GR851085B (fr) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
WO1987005296A1 (fr) * 1986-03-07 1987-09-11 Pfizer Inc. 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles et composes apparentes utilises en tant qu'agents de traitement ou de prevention des ulceres
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
FR2614618B1 (fr) * 1987-04-30 1989-07-07 Cird Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
AU617217B2 (en) * 1988-09-20 1991-11-21 Hisamitsu Pharmaceutical Co., Inc. Novel dibenz(b,e)oxepin derivatives
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US5395952A (en) * 1991-06-03 1995-03-07 Sumitomo Chemical Company, Limited Benzimidazole derivatives agricultural and horticultural fungicides containing the same as an active ingredient and intermediate compounds thereof
NZ318501A (en) * 1995-09-21 1999-06-29 Pharma Pass Llc Novel composition containing an acid-labile omeprazole and process for its preparation
DE19745692A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten
DK1044189T4 (en) * 1997-12-31 2015-03-30 Pfizer Prod Inc Aryl-fused fused azapolycyclic connections
IL166313A0 (en) * 2002-07-17 2006-01-15 Kyoto Pharma Ind Indoline derivatives and pharmaceutical compositions containing the same
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
CN102140099A (zh) 2010-02-02 2011-08-03 山东轩竹医药科技有限公司 新的吡啶衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE5129C1 (fr) 1894-05-19
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fr) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746667A (en) * 1981-08-13 1988-05-24 Aktiebolaget Hassle Pharmaceutical composition containing 2-(2-benzimidazolyl thiomethyl) pyridine
EP0233284B1 (fr) * 1985-10-29 1992-08-19 Aktiebolaget Hässle Composes pharmaceutiques
EP0510719A1 (fr) 1986-11-21 1992-10-28 Aktiebolaget Hässle Dérivés de benzimidazol substitués par un group radical et leur utilisation pour l'inhibition de la sécrétion gastrique
LT3810B (en) 1986-11-21 1996-03-25 Haessle Ab New benzimidazole derivatives, a process for production thereof and a pharmaceuticalcomposition containing the same

Also Published As

Publication number Publication date
IE811912L (en) 1982-02-21
CA1134829A (fr) 1982-11-02
LU83571A1 (de) 1983-06-08
ATA364381A (de) 1984-05-15
DK300981A (da) 1982-02-22
JPS5770886A (en) 1982-05-01
IT1138156B (it) 1986-09-17
IL63576A0 (en) 1981-11-30
IE51507B1 (en) 1987-01-07
AT376665B (de) 1984-12-27
NZ198047A (en) 1985-05-31
US4435406A (en) 1984-03-06
IT8123556A0 (it) 1981-08-18
FR2488890B1 (fr) 1985-01-11
ZA815633B (en) 1982-08-25
US4599347A (en) 1986-07-08
GB2082580B (en) 1984-03-07
SE8104941L (sv) 1982-02-22
PH17937A (en) 1985-02-05
GB2082580A (en) 1982-03-10
IL63576A (en) 1985-10-31
DE3132613A1 (de) 1982-06-24
AU541834B2 (en) 1985-01-24
AU7408981A (en) 1982-02-25
CH644116A5 (de) 1984-07-13
NL8103690A (nl) 1982-03-16
FR2488890A1 (fr) 1982-02-26
US4554280A (en) 1985-11-19
SE452765B (sv) 1987-12-14

Similar Documents

Publication Publication Date Title
BE890024A (fr) Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques
BE889930A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
BE889929A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
BE887800A (fr) Derives de carbostyrile, leurs procedes de preparation et leur application en therapeutique
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
FR2459808B1 (fr) Polyoxypropylene-urethanes, leur preparation et leurs utilisations
FR2545825B1 (fr) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, leur preparation et leurs utilisations therapeutiques
BE868882A (fr) Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2585018B1 (fr) Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques
FR2342724A1 (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
FR2330404A1 (fr) Derives de la 1,4-diazepine, leur preparation et leurs utilisations therapeutiques
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
BE857576A (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
BE883943A (fr) Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques, notamment comme analgesiques
BE864484A (fr) Benzylpyridimines, leur preparation et leurs utilisations therapeutiques
IT1167276B (it) Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia
MA19145A1 (fr) Derives de la phenylpropargylamine et leur application comme rodenticides .
OA06816A (fr) Dérivés de benzazole, leur préparation et leurs utilisations thérapeutiques.
FR2508457B1 (fr) Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques
FR2516509B1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
BE859213A (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
BE868570A (fr) Derives d'acides tetranaphtalenesulfoniques, leur preparation et leurs utilisations therapeutiques
FR2477151B1 (fr) Derives de la piperazine, leur preparation et leurs utilisations en medecine
MC1419A1 (fr) Derives de l'imidazole,leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CIE S.A.

Effective date: 19880831